Back to search
Post-menopausal Osteoporosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Post-menopausal Osteoporosis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Post-menopausal Osteoporosis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
During menopause, estrogen levels drop while the level of another hormone - LH (luteinizing hormone) substantially increases. This hormonal shift is linked to b…
Denosumab (Dmab) is a treatment for postmenopausal osteoporosis. However, its withdrawal is associated with a rebound phenomenon associated with an unexpected i…
This study aims to evaluate the adherence of patients to combined treatment with bisphosphonates and calcium and vitamin D supplements, which is one of the usua…
Post-menopausal osteoporosis and the resulting fractures are an important cause of disability and loss of independence. They also increase the risk of morbidity…
This study will be conducted to determine the effect of circuit training on bone mineral density in post menopausal period.
12-month prospective, open-label, multicenter, international, observational study evaluating sequential treatments after osteoanabolics
The goal of this clinical trial is to learn if romosozumab (Evenity) can improve bone and muscle health in postmenopausal women with osteoporosis who are underg…
This study is designed as on observational, retrospective, and prospective clinical registry aimed at collecting comprehensive real-world data on women in perim…